Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Safety Profile and Clinical Response To MEDI-551, a Humanized Monoclonal Anti-CD19, In a Phase 1/2 Study In Adults With Relapsed Or Refractory Advanced B-Cell Malignancies

Andres Forero-Torres, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Celeste M. Bello, MD, Thomas J. Kipps, MD, PhD, Fritz Offner, MD, Gregor Verhoef, Massimo Federico, MD, Stephanie A. Gregory, MD, Anne Sonet, MD, Sarit Assouline, MD, Jaime Pérez de Oteyza, Jose Francisco Tomas, MD, Antonio Cuneo, MD, Nairouz Elgeioushi, MPH, Trishna Goswami, MD, Ramy Ibrahim, MD, Ronald Herbst, PhD, Bruce D. Cheson, M.D.

Blood (2013) 122 (21): 1810.

https://doi.org/10.1182/blood.V122.21.1810.1810

Published: 2013

Journal Articles

Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia

Steven Peter Treon, MD, MA, PhD, Christina K Tripsas, MA, Kirsten Meid, MPH, Christopher Patterson, Leonard T Heffner, MD, Herbert Eradat, MS, MD, Stephanie A. Gregory, MD, Sheeba K. Thomas, M.D., Ranjana H. Advani, MD, Rachid Baz, Ashraf Z. Badros, MD, Jeffrey Matous, MD, Timothy J. Murphy, MD, FACP, Irene M. Ghobrial, MD

Blood (2013) 122 (21): 1822.

https://doi.org/10.1182/blood.V122.21.1822.1822

Published: 2013

Journal Articles

Multicenter Analysis Of Primary Central Nervous System Lymphoma: Patient Characteristics, Treatment Patterns and Survival

Reem Karmali, MD, Michael De Vita, MD, Adam M. Petrich, MD, Chadi Nabhan, MD, FACP, Kimberly Kruczek, DO, Jeffrey Raizer, MD, Daniel McFarland, DO, David Peace, MD, Rimas Lukas, MD, Sanjib Basu, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2013) 122 (21): 1803.

https://doi.org/10.1182/blood.V122.21.1803.1803

Published: 2013

Journal Articles

Ofatumumab (OFA) in Combination with CHOP for Previously Untreated Follicular Lymphoma: Follow-up Results

Myron S. Czuczman, MD, Georg Hess, Ole Gadeberg, Lars Moeller Pedersen, Per Hansen, David Belada, M.D., Ph.D., Stephanie A. Gregory, MD, Brad Pohlman, MD, Jiri Mayer, M.D., PhD., Prof., Robert Pytlik, Lorenz Trumper, Andreas Viardot, MD, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Paul Winter, Nancy Goldstein, Roxanne C. Jewell, PhD, Steen Lisby, MD, DMSc

Blood (2012) 120 (21): 1632.

https://doi.org/10.1182/blood.V120.21.1632.1632

Published: 2012

Journal Articles

Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)

Clemens Wendtner, MD, Michael Hallek, MD, Graeme Fraser, Anne-Sophie Michallet, MD, PhD, Peter Hillmen, Jan Duerig, Stephanie A. Gregory, MD, Matt Kalaycio, MD, Stephan Stilgenbauer, MD, Andreas Buehler, Thomas J. Kipps, MD, PhD, Brendan Purse, Jennie Zhang, Jay Mei, MD, PhD, Asher Chanan-Khan, MD

Blood (2012) 120 (21): 3925.

https://doi.org/10.1182/blood.V120.21.3925.3925

Published: 2012

Journal Articles

MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study

Blood (2012) 120 (21): 3677.

https://doi.org/10.1182/blood.V120.21.3677.3677

Published: 2012

Journal Articles

Engraftment Kinetics After Alimtuzumab-Based Allogeneic Stem Cell Transplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVHD) or CMV Reactivation

Henry C. Fung, FRCP, MD, Muhammed Alikhan, Lela Buckingham, PhD, John J. Maciejewski, MD, PhD, Reem Karmali, MD, Kent W Christopherson, II, PhD, Elizabeth Shima Rich, MD, PhD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Sunita Nathan, MD

Blood (2012) 120 (21): 4162.

https://doi.org/10.1182/blood.V120.21.4162.4162

Published: 2012

Journal Articles

Incidence and Characteristics of Therapy-Related Myeloid Neoplasms in Patients with Non-Hodgkins Lymphoma Treated with Radioimmunotherapy

Salman Waheed, MD, Iva Ferreira, MD, Deborah A. Katz, MD, Reem Karmali, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Jamile M. Shammo, MD

Blood (2012) 120 (21): 4924.

https://doi.org/10.1182/blood.V120.21.4924.4924

Published: 2012

Journal Articles

Prospective, Multicenter Study of the MTOR Inhibitor Everolimus (RAD001) As Primary Therapy in Waldenstrom's Macroglobulinemia

Steven P Treon, MD, PhD, Christina K Tripsas, Leukothea Ioakimidis, Diane Warren, Christopher Patterson, Leonard Heffner, MD, Herbert Eradat, MD, MS, Stephanie A. Gregory, MD, Sheeba Thomas, MD, Ranjana Advani, MD, Rachid Baz, Ashraf Z. Badros, MD, Jeffrey Matous, MD, Kenneth C. Anderson, MD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 2951.

https://doi.org/10.1182/blood.V118.21.2951.2951

Published: 2011

Journal Articles

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

Henry C. Fung, FRCP, MD, Sunita Nathan, MD, Neel B. Shah, MD, John J. Maciejewski, MD, PhD, Elizabeth Shima Rich, MD, PhD, Jennifer Tornatta, MS, ANP, Nancy Licciardi, Parameswaran Venugopal, MD, Reem Karmali, MD, Stephanie A. Gregory, MD

Blood (2011) 118 (21): 4205.

https://doi.org/10.1182/blood.V118.21.4205.4205

Published: 2011

Journal Articles

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, DO, MSc, Irene Helenowski, MS, Chadi Nabhan, MD, FACP, Erika Ramsdale, MD, June M McKoy, MD, JD, MPH, MBA, Annette Larsen, B.A., R.N., Sarah Miyata, RN, MSN, ACNP, Benjamin Parsons, DO, Reem Karmali, MD, Britt E. Hanson, DO, Leo I. Gordon, MD, FACP, Scott E. Smith, MD, PhD, FACP, Stephanie A. Gregory, MD, Sonali M. Smith, MD

Blood (2011) 118 (21): 2625.

https://doi.org/10.1182/blood.V118.21.2625.2625

Published: 2011

Journal Articles

Integration of Rituximab and Liposomal Doxorubicin (DOXIL®) Into CODOX-M/IVAC for HIV-Negative and HIV+ Adults with Untreated Burkitt's Lymphoma (BL): Results of a Prospective Multicenter Phase II Study

Andrew M. Evens, DO, MSc, Kenneth R. Carson, MD, Chadi Nabhan, MD, FACP, Borko Jovanovic, PhD, Paul Barr, MD, Lilia Gallot, Irene Helenowski, MS, Paolo F. Caimi, MD, Stephanie A. Gregory, MD, Leo I. Gordon, MD, FACP

Blood (2011) 118 (21): 2669.

https://doi.org/10.1182/blood.V118.21.2669.2669

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum

Laura A Paganessi, MA, Robin R Frank, BS, Sucheta Jagan, MS, Reem Karmali, MD, Yan Li, Youping Deng, Cristina L Fhied, Jeffrey A Borgia, PhD, Melissa L Larson, M.D., Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD

Blood (2011) 118 (21): 2646.

https://doi.org/10.1182/blood.V118.21.2646.2646

Published: 2011

Journal Articles

Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant,

Jennifer Tornatta, MS, ANP, John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Bruce Mcleod, MD, Sridevi Palaparthy, MBA, MS, Elizabeth Shima Rich, MD, PhD, Kent W Christopherson, II, PhD, Stephanie A. Gregory, MD, Henry C. Fung, FRCP, MD

Blood (2011) 118 (21): 4061.

https://doi.org/10.1182/blood.V118.21.4061.4061

Published: 2011

Journal Articles

Multicenter Analysis of Very Elderly Indolent and Aggressive Non-Hodgkin Lymphoma (NHL): Impact of Functional Status on Outcome,

Chadi Nabhan, MD, FACP, Sonali M. Smith, MD, Irene Helenowski, MS, Erika Ramsdale, MD, Reem Karmali, MD, Benjamin Parsons, DO, Josephine L. Feliciano, MD, Britt E. Hanson, DO, Scott E. Smith, MD, PhD, FACP, Annette Larsen, B.A., R.N., June M. McKoy, MD, MPH, JD, MBA, Stephanie A. Gregory, MD, Andrew M. Evens, DO, MSc

Blood (2011) 118 (21): 3668.

https://doi.org/10.1182/blood.V118.21.3668.3668

Published: 2011

Journal Articles

CD20, CD22, CD23, but Not CD37 Expression on CD19 + B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients,

Robin R Frank, BS, Sucheta Jagan, MS, Laura A Paganessi, MA, Melissa L Larson, M.D., Reem Karmali, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD

Blood (2011) 118 (21): 3685.

https://doi.org/10.1182/blood.V118.21.3685.3685

Published: 2011

Journal Articles

Comparison of Survival Outcomes of Patients with Mantle Cell Lymphoma (MCL) Treated with Autologous Stem Cell Transplant (ASCT) and Conventional Chemotherapy

Daniel C McFarland, D.O., Parameswaran Venugopal, MD, Yan Li, Youping Deng, Stephanie A. Gregory, MD

Blood (2011) 118 (21): 4491.

https://doi.org/10.1182/blood.V118.21.4491.4491

Published: 2011

Journal Articles

Improving Patient Care Through Interprofessional Education

Linda M. Ritter, PhD, Susan A. Berry, BS, Stephanie A. Gregory, MD, Jonathan L. Kaufman, MD, Sean T. Walsh, BA, Brian F. Tyburski, BS

Blood (2011) 118 (21): 4764.

https://doi.org/10.1182/blood.V118.21.4764.4764

Published: 2011

Journal Articles

Primary Central Nervous System Lymphoma (PCNSL) in Immunocompetent Patients: An Analysis of Prognostic Factors and Treatment Strategies

Daniel C McFarland, D.O., Stephanie A. Gregory, MD, Yan Li, Youping Deng, Parameswaran Venugopal, MD

Blood (2011) 118 (21): 4955.

https://doi.org/10.1182/blood.V118.21.4955.4955

Published: 2011

Journal Articles

Favorable Outcomes of Neutropenic Enterocolitis Following Hematopoietic Stem Cell Transplantation (HSCT) Using a Conservative Medical Therapy Approach.

Antonio M. Jimenez, MD, George Behrens, MD, John Maciejewski, MD, PhD, Norman Wool, MD, Elizabeth Shima Rich, MD, PhD, Reem Karmali, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Henry C. Fung, FRCP, MD, Sunita Nathan, MD

Blood (2010) 116 (21): 1283.

https://doi.org/10.1182/blood.V116.21.1283.1283

Published: 2010

NARROW

Safety Profile and Clinical Response To MEDI-551, a Humanized Monoclonal Anti-CD19, In a Phase 1/2 Study In Adults With Relapsed Or Refractory Advanced B-Cell Malignancies

Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia

Multicenter Analysis Of Primary Central Nervous System Lymphoma: Patient Characteristics, Treatment Patterns and Survival

Ofatumumab (OFA) in Combination with CHOP for Previously Untreated Follicular Lymphoma: Follow-up Results

Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)

MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study

Engraftment Kinetics After Alimtuzumab-Based Allogeneic Stem Cell Transplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVHD) or CMV Reactivation

Incidence and Characteristics of Therapy-Related Myeloid Neoplasms in Patients with Non-Hodgkins Lymphoma Treated with Radioimmunotherapy

Prospective, Multicenter Study of the MTOR Inhibitor Everolimus (RAD001) As Primary Therapy in Waldenstrom's Macroglobulinemia

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Integration of Rituximab and Liposomal Doxorubicin (DOXIL®) Into CODOX-M/IVAC for HIV-Negative and HIV+ Adults with Untreated Burkitt's Lymphoma (BL): Results of a Prospective Multicenter Phase II Study

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum

Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant,

Multicenter Analysis of Very Elderly Indolent and Aggressive Non-Hodgkin Lymphoma (NHL): Impact of Functional Status on Outcome,

CD20, CD22, CD23, but Not CD37 Expression on CD19 + B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients,

Comparison of Survival Outcomes of Patients with Mantle Cell Lymphoma (MCL) Treated with Autologous Stem Cell Transplant (ASCT) and Conventional Chemotherapy

Improving Patient Care Through Interprofessional Education

Primary Central Nervous System Lymphoma (PCNSL) in Immunocompetent Patients: An Analysis of Prognostic Factors and Treatment Strategies

Favorable Outcomes of Neutropenic Enterocolitis Following Hematopoietic Stem Cell Transplantation (HSCT) Using a Conservative Medical Therapy Approach.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only